NCT04933721 - Open-label Berotralstat Access to HAE Patients Previously Enrolled in Berotralstat Studies | Biotech Hunter

Enrollment

139

Participants

Timeline

Start Date

July 23, 2021

Primary Completion Date

August 31, 2031

Study Completion Date

August 31, 2031

Conditions

Hereditary AngioedemaHAE

Interventions

DRUG

berotralstat

BCX7353 capsules or granules administered orally once daily

Trial Locations (13)

Study Center, Ottawa

Study Center, Brno

Study Center, Pilsen

Study Center, Grenoble

Study Center, Paris

Study Center, Skopje

Study Center, Krakow

Study Center, Martin

Study Center, Cape Town

Study Center, Daegu

Study Center, Gwangju

Study Center, Seoul

Study Center, Bristol